Early neurological deterioration in acute ischaemic stroke: Predictors, mechanisms and management

Postgraduate Medical Journal

Volumn 84, Issue 994, 2008, Pages 412-417

  Thanvi, B ^a   Treadwell, S ^b   Robinson, T ^c  

^a SOUTH WARWICKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR;

BLOOD VESSEL OCCLUSION; BRAIN DECOMPRESSION; BRAIN EDEMA; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; EMBOLECTOMY; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MORBIDITY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; RECANALIZATION; RECURRENT DISEASE; REVIEW; SEIZURE;

BRAIN EDEMA; BRAIN ISCHEMIA; COLLATERAL CIRCULATION; DISEASE PROGRESSION; HUMANS; NERVOUS SYSTEM DISEASES; SEIZURES; STROKE; TERMINOLOGY AS TOPIC;

EID: 53749091672     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.066118     Document Type: Review

References (65)

1. Karepov VG, Gur AY, Bova I, et al. Stroke-in-evolution: infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis 2006;21:42-6.
2. Yamamoto H, Bogousslavsky J, van Melle G. Different predictors of neurological worsening in different causes of stroke. Arch Neurol 1998;55:481-6.
3. Davalos A, Toni D, Iweins F, et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30:2631-6.
4. Tei H, Uchiyama S, Ohara K, et al. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000;31:2049-54.
5. Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. OJM 2006;99:625- 33.
6. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754-62
7. Marti-Vilata JL, Arboix A. The Barcelona Stroke Registry. Eur Neurol 1999;41:135-42.
8. Weimar C, Mieck T, Buchthal J, et al for the German Stroke Study Collaboration. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005;62:393-7.
9. Steinke W, Ley SC. Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002;33:1510-6.
10. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebmvasc Dis 2004;17:242-52.
11. DeGraba TJ, Hallenbeck JM, Pettigrew KD, et al. Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999;30:1208-12.
12. Bruno A, Biller J, Adams HPJr, et al for the Trial of 0RG 10172 in Acute Stroke Treatment (TOAST) Investigators. Acute blood glucose level and outcome from ischemic stroke. Neurology 1999;52:280-4.
13. Bruno A, Levine SR, Frankel MR, et al for the NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669-74.
14. Davalos A, Castillo J. Potential mechanisms of worsening. Cerebrovasc Dis 1997;7(suppl 5):19-24.
15. Toni D, Fiorelli M, Gentile M, et al. Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol 1995;52:670-5.
16. Davalos A, Cendra E, Teruel J, et al. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865-9.
17. Jorgensen HS, Nakayama H, Raaschou HO, et al. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994;344:156-9.
18. Barber M, Wright F, Stott DJ, et al. Predictors of early neurological deterioration after ischaemic stroke: a case-control study. Gerontology 2004;50:102-9.
19. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-14.
20. lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 2004;35:363-4.
21. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20-8.
22. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603-10.
23. Candelise L, Landi G, Orazio EN, et al. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 1985;42:661-3.
24. Gray CS, Hildreth AJ, Sandercock PA, et al. for the GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406.
25. Castillo J, Leira R, Garcia MM, et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520-6.
26. Potter J, Robinson T, Ford G, et al for the CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design. J Hypertens 2005;23:649-55.
27. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006;1:245-9.
28. COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens 2005;23:455-8.
29. Schollinger PD, Fiebach JB. Jansen O. et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001;49:460-9.
30. Rajajes V, Kidwell C, Starkman S. et al. Early MRI and outcomes or untreated patients with mild or improving ischemic stroke. Neurology 2006;67:980-4.
31. Irino T, Watanabe M, Nishide M, et al. Angjographical analysis of acute cerebral infarction followed by "cascade"-like deterioration of minor neurological deficits. What is progressing stroke? Stroke 1983;14:363-8.
32. Captan LR, Worsening in ischemic stroke patients: is it time for a new strategy? Stroke 2002;33:1443-5.
33. Pubsinelli W, Pathophysiology of acute ischaemic stroke. Lancet 1992;339:533-6.
34. Toni D, De Michele M, Fiorelli M, et al. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci 1994;123:129-33.
35. Ali LK, Saver JL The ischemic stroke patient who worsens: new assessment and management approaches. Rev Neurol Dis 2007;4:85-91.
36. Akopov S, Whitman GT. Hemodynamic studies in early ischemic stroke: serial transcranial Doppler and magnetic resonance angiography evaluation. Stroke 2002;33:1274-9.
37. Fisher CM, The use of anticoagulants in cerebral thrombosis. Neurology 1958;8:311-32.
38. Rothwell PM, Giles MF, Chandratheva A, et al for the Early use of Existing Preventive Strategies for Stroke (EXPRESS) Study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison, Lancet 2007;370:1432-42.
39. Kang DW, Latour LL, Chalela JA, et al. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol 2003;54:66-74.
40. Kang DW, Chu K, Ko SB, et al. Lesion patterns and mechanism of ischemia in internal carotid artery disease: a diffusion-weighted imaging study. Arch Neurol 2002;59:1577-82.
41. Valton L, Larrue V, le Traon AP, et al. Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke 1998;29:2125-8.
42. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862-7.
43. Berrouschot J, Sterker M, Bettin S, et al. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. intensive Care Med 1998;24:620-3.
44. Oppenbeim C, Samson Y, Manai R, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000;31:2175-81.
45. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
46. National Institute of Neurological Disorders, Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
47. Smith WS, Sung G, Starkman S, et al for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Sfrote. 2005;36:1432-8.
48. Larrue V, von Kummer R, del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957-60.
49. Barger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? stroke 2001;32:1330-5.
50. Saver JL, Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Sfrote 2007;38:2279-83.
51. Alexaadrav AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen. Neurology 2002;59:862-7.
52. Rubiera M, Alvarez-Sabin J, Ribo M, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Sfrote 2005;36:1452-6.
53. Johnston KC, Li JY, Lyden PD. et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Sfroke 1998;29:447-53.
54. Bogousslavsky J, Martin R, Regli F, et al. Persistent worsening of stroke sequelae after delayed seizures. Arch Neurol 1992;49:385-8.
55. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003;60:1441-6.
56. Hillis AE, Ulatowski JA. Barker PB, et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003;16:236-46.
57. Lylyk P, Vila JF, Miranda C, et al. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 2005;27(Suppl 1):S129-35.
58. Rothwell PM, Giles MF, Chandratheva A. et al for the Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS
59. The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT). Lancet 2006;367:1665-73.
60. Diener HC, Sacco R, Yusuf S, Steering Committee for the PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extendedrelease dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007;23:368-80.
61. Kennedy J, Hill MD, Ryckborst KJ, et al. Fast Assessment of Stroke and Transient ischaemic attack to prevent Early Recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007;6:961-9.
62. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 9435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
63. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-534.
64. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-93.
65. Vahedi K, Hofmeijer J, Juettler E, et al, for the DESTINY, and HAMLET Investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215-22.